Platelet Function Diagnostics via Shear Stress and Segmented Activators
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for determining platelet function, especially under flow conditions, are inadequate for accurately assessing the antithrombotic effects of P2Y(12) antagonists like clopidogrel and P2Y(1) antagonists, particularly when used in conjunction with aspirin, due to limited sensitivity and the need for precise measurement of platelet aggregation under physiological shear forces.
Innovation Solution
An in vitro method using a whole blood sample that simulates physiological flow conditions by passing blood through a capillary with a separating element coated with ADP, prostaglandin E1, and calcium ions, measuring the time required for platelet plug formation to assess platelet function and the antithrombotic effect of these antagonists.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional methods for determining platelet function are used, then the measurement can be performed with simple equipment, but the sensitivity and accuracy for detecting P2Y(12) and P2Y(1) antagonist effects are insufficient
Solution Approach 1:
The measuring chamber is divided into two compartments by a separating element, allowing independent placement of different activators (ADP on one side, prostaglandin E1 and calcium ions on the other) to specifically target P2Y(12) and P2Y(1) receptors respectively, thereby improving detection sensitivity without requiring a completely complex system redesign
Solution Approach 2:
A separating element acts as an intermediary structure that enables controlled interaction between blood and specific activators while maintaining flow conditions, allowing precise measurement of antagonist effects without direct complex intervention in the blood sample handling
2Reliability
If aspirin is present in the blood sample, then COX-1 inhibition is demonstrated, but false positives occur in detecting P2Y(12) and P2Y(1) antagonist effects
Solution Approach 1:
The method separates the detection of P2Y(12) and P2Y(1) antagonist effects from the aspirin effect by using specific activators that bypass the COX-1 pathway. ADP directly activates P2Y(12) receptors while prostaglandin E1 and calcium ions target P2Y(1) receptors, extracting the specific receptor-mediated aggregation response from the overall platelet function that would otherwise be confounded by aspirin's COX-1 inhibition
Solution Approach 2:
Different regions of the measuring system are assigned different activators with specific specificities: ADP is placed to specifically challenge P2Y(12) receptor function, while prostaglandin E1 and calcium ions challenge P2Y(1) receptor function. This local differentiation of activator properties allows reliable detection of antagonist effects even in the presence of aspirin, as each region tests a specific receptor pathway independently of COX-1 status
3Measurement precision
If platelet function is determined under static conditions, then the test procedure is simple, but the physiological relevance for assessing antithrombotic therapy is reduced
Solution Approach 1:
The system transitions from static to dynamic conditions by introducing blood flow through the capillary into the measuring chamber. The flow creates physiological shear forces that activate platelets in a manner more representative of in vivo conditions, thereby improving physiological relevance while using a relatively simple flow generation mechanism
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method provides a more sensitive and accurate determination of platelet dysfunction induced by P2Y(12) and P2Y(1) antagonists, while minimizing the impact of aspirin, allowing for better differentiation between antithrombotic effects and reducing false positives from aspirin-induced platelet dysfunction.
Implementation Method 1
simulates physiological flow conditions by passing blood through a capillary with a separating element coated with ADP, prostaglandin E1, and calcium ions
Implementation Method 2
passing blood through a capillary with a separating element coated with ADP, prostaglandin E1, and calcium ions, measuring the time required for platelet plug formation
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The invention lies in the field of platelet function diagnostics and relates to a method for determining platelet function under flow conditions and a device for carrying out this method. The method is particularly suitable for determining the effect of clopidogrel and other antithrombotic P2Y(12) antagonists, as well as for determining antithrombotic P2Y(1) antagonists.